Breast Cancer Liquid Biopsy Market Report

Global and Region Breast Cancer Liquid Biopsy Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：139
  • REPORT CODE：GMM909827
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.

    The report details the trend, potential and market size of Breast Cancer Liquid Biopsy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Breast Cancer Liquid Biopsymarket, defines the market attractiveness level of Breast Cancer Liquid Biopsy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Breast Cancer Liquid Biopsy industry, describes the types of Breast Cancer Liquid Biopsy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Breast Cancer Liquid Biopsy market and the development prospects and opportunities of Breast Cancer Liquid Biopsy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Breast Cancer Liquid Biopsy market in Chapter 13.

    By Player:

    • MDx Health

    • Thermo Fisher Scientific

    • Guardant Health

    • Genomic Health

    • Illumina

    • Menarini Silicon Biosystems

    • RainDance Technologies

    • Roche Diagnostics

    • Myriad Genetics

    • Biocept

    • Trovagene

    • Bio-Rad Laboratories

    • QIAGEN

    By Type:

    • Circulating Tumor Cells (CTCs)

    • Cell-Free DNA (CfDNA)

    • Extracellular Vesicles (EVs)

    • Other Circulating Biomarkers

    By End-User:

    • Hospitals

    • Diagnostic Centers

    • Laboratories

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Breast Cancer Liquid Biopsy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Breast Cancer Liquid Biopsy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Breast Cancer Liquid Biopsy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Breast Cancer Liquid Biopsy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Breast Cancer Liquid Biopsy Market Analysis and Outlook to 2022

    • 7.1 Global Breast Cancer Liquid Biopsy Consumption (2017-2022)

    • 7.2 United States Breast Cancer Liquid Biopsy Consumption (2017-2022)

    • 7.3 Europe Breast Cancer Liquid Biopsy Consumption (2017-2022)

    • 7.4 China Breast Cancer Liquid Biopsy Consumption (2017-2022)

    • 7.5 Japan Breast Cancer Liquid Biopsy Consumption (2017-2022)

    • 7.6 India Breast Cancer Liquid Biopsy Consumption (2017-2022)

    • 7.7 South Korea Breast Cancer Liquid Biopsy Consumption (2017-2022)

    8 Region and Country-wise Breast Cancer Liquid Biopsy Market Analysis and Outlook to 2028

    • 8.1 Global Breast Cancer Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.2 United States Breast Cancer Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.3 Europe Breast Cancer Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.4 China Breast Cancer Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.5 Japan Breast Cancer Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.6 India Breast Cancer Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.7 South Korea Breast Cancer Liquid Biopsy Consumption Forecast (2022-2028)

    9 Global Breast Cancer Liquid Biopsy Market Outlook by Types and Applications to 2022

    • 9.1 Global Breast Cancer Liquid Biopsy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Circulating Tumor Cells (CTCs) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cell-Free DNA (CfDNA) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Extracellular Vesicles (EVs) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Circulating Biomarkers Consumption and Growth Rate (2017-2022)

    • 9.2 Global Breast Cancer Liquid Biopsy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Laboratories Consumption and Growth Rate (2017-2022)

    10 Global Breast Cancer Liquid Biopsy Market Outlook by Types and Applications to 2028

    • 10.1 Global Breast Cancer Liquid Biopsy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Circulating Tumor Cells (CTCs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Cell-Free DNA (CfDNA) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Extracellular Vesicles (EVs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Circulating Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Breast Cancer Liquid Biopsy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Laboratories Consumption Forecast and Growth Rate (2022-2028)

    11 Global Breast Cancer Liquid Biopsy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Breast Cancer Liquid Biopsy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Breast Cancer Liquid Biopsy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Breast Cancer Liquid Biopsy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Breast Cancer Liquid Biopsy Market Competitive Analysis

    • 14.1 MDx Health

      • 14.1.1 MDx Health Company Details

      • 14.1.2 MDx Health Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 MDx Health Breast Cancer Liquid Biopsy Product and Service

    • 14.2 Thermo Fisher Scientific

      • 14.2.1 Thermo Fisher Scientific Company Details

      • 14.2.2 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product and Service

    • 14.3 Guardant Health

      • 14.3.1 Guardant Health Company Details

      • 14.3.2 Guardant Health Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Guardant Health Breast Cancer Liquid Biopsy Product and Service

    • 14.4 Genomic Health

      • 14.4.1 Genomic Health Company Details

      • 14.4.2 Genomic Health Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Genomic Health Breast Cancer Liquid Biopsy Product and Service

    • 14.5 Illumina

      • 14.5.1 Illumina Company Details

      • 14.5.2 Illumina Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Illumina Breast Cancer Liquid Biopsy Product and Service

    • 14.6 Menarini Silicon Biosystems

      • 14.6.1 Menarini Silicon Biosystems Company Details

      • 14.6.2 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product and Service

    • 14.7 RainDance Technologies

      • 14.7.1 RainDance Technologies Company Details

      • 14.7.2 RainDance Technologies Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 RainDance Technologies Breast Cancer Liquid Biopsy Product and Service

    • 14.8 Roche Diagnostics

      • 14.8.1 Roche Diagnostics Company Details

      • 14.8.2 Roche Diagnostics Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Roche Diagnostics Breast Cancer Liquid Biopsy Product and Service

    • 14.9 Myriad Genetics

      • 14.9.1 Myriad Genetics Company Details

      • 14.9.2 Myriad Genetics Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Myriad Genetics Breast Cancer Liquid Biopsy Product and Service

    • 14.10 Biocept

      • 14.10.1 Biocept Company Details

      • 14.10.2 Biocept Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Biocept Breast Cancer Liquid Biopsy Product and Service

    • 14.11 Trovagene

      • 14.11.1 Trovagene Company Details

      • 14.11.2 Trovagene Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Trovagene Breast Cancer Liquid Biopsy Product and Service

    • 14.12 Bio-Rad Laboratories

      • 14.12.1 Bio-Rad Laboratories Company Details

      • 14.12.2 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product and Service

    • 14.13 QIAGEN

      • 14.13.1 QIAGEN Company Details

      • 14.13.2 QIAGEN Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 QIAGEN Breast Cancer Liquid Biopsy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Breast Cancer Liquid Biopsy

    • Figure Breast Cancer Liquid Biopsy Picture

    • Table Global Breast Cancer Liquid Biopsy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Breast Cancer Liquid Biopsy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Breast Cancer Liquid Biopsy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Breast Cancer Liquid Biopsy Consumption by Country (2017-2022)

    • Figure United States Breast Cancer Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Table Europe Breast Cancer Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Figure China Breast Cancer Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Figure Japan Breast Cancer Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Figure India Breast Cancer Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Breast Cancer Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Liquid Biopsy Consumption Forecast by Country (2022-2028)

    • Figure United States Breast Cancer Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Breast Cancer Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Breast Cancer Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Breast Cancer Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Breast Cancer Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Breast Cancer Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Circulating Tumor Cells (CTCs) Consumption and Growth Rate (2017-2022)

    • Figure Global Cell-Free DNA (CfDNA) Consumption and Growth Rate (2017-2022)

    • Figure Global Extracellular Vesicles (EVs) Consumption and Growth Rate (2017-2022)

    • Figure Global Other Circulating Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Circulating Tumor Cells (CTCs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cell-Free DNA (CfDNA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Extracellular Vesicles (EVs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Circulating Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Breast Cancer Liquid Biopsy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Breast Cancer Liquid Biopsy Export by Region (Top 5 Countries) (2017-2028)

    • Table MDx Health (Foundation Year, Company Profile and etc.)

    • Table MDx Health Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table MDx Health Breast Cancer Liquid Biopsy Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product and Service

    • Table Guardant Health (Foundation Year, Company Profile and etc.)

    • Table Guardant Health Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guardant Health Breast Cancer Liquid Biopsy Product and Service

    • Table Genomic Health (Foundation Year, Company Profile and etc.)

    • Table Genomic Health Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomic Health Breast Cancer Liquid Biopsy Product and Service

    • Table Illumina (Foundation Year, Company Profile and etc.)

    • Table Illumina Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Breast Cancer Liquid Biopsy Product and Service

    • Table Menarini Silicon Biosystems (Foundation Year, Company Profile and etc.)

    • Table Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product and Service

    • Table RainDance Technologies (Foundation Year, Company Profile and etc.)

    • Table RainDance Technologies Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table RainDance Technologies Breast Cancer Liquid Biopsy Product and Service

    • Table Roche Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Roche Diagnostics Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Diagnostics Breast Cancer Liquid Biopsy Product and Service

    • Table Myriad Genetics (Foundation Year, Company Profile and etc.)

    • Table Myriad Genetics Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myriad Genetics Breast Cancer Liquid Biopsy Product and Service

    • Table Biocept (Foundation Year, Company Profile and etc.)

    • Table Biocept Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocept Breast Cancer Liquid Biopsy Product and Service

    • Table Trovagene (Foundation Year, Company Profile and etc.)

    • Table Trovagene Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Trovagene Breast Cancer Liquid Biopsy Product and Service

    • Table Bio-Rad Laboratories (Foundation Year, Company Profile and etc.)

    • Table Bio-Rad Laboratories Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product and Service

    • Table QIAGEN (Foundation Year, Company Profile and etc.)

    • Table QIAGEN Breast Cancer Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN Breast Cancer Liquid Biopsy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US